4//SEC Filing
Huntsman Ronald Kirk 4
Accession 0001493152-24-025688
CIK 0001716166other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 8:53 PM ET
Size
7.2 KB
Accession
0001493152-24-025688
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20$2.38/sh+20,000$47,600→ 49,334 totalExercise: $2.38Exp: 2029-06-20→ Common Stock (20,000 underlying)
Holdings
- 69,600(indirect: See footnote)
Common Stock
- 3,461
Common Stock
Footnotes (2)
- [F1]Shares held by Coronado V Partners, LLC, of which the Reporting Person is a member and manager.
- [F2]On June 20, 2024 (the "Grant Date"), the Reporting Person received a grant of 20,000 stock options from the Issuer. One-fifth vested immediately and one-fifth will vest annually on each anniversary of the Grant Date through June 20, 2028.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001835498
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 8:53 PM ET
- Size
- 7.2 KB